Professional Documents
Culture Documents
manufacturingcompatible
of CAR-T
induced pluripotent stem
cells from
cells (iPSC)
RATCHAPONG
1
NETSRITHONG
2
Limitations of adoptive T cell therapy
Expand modified
Collect T cells from Modify T cells
• T cells
peripheral blood Chimeric antigen
Transfer cells to the patient
Patient receptors (CARs)
• Transgenic TCR
T cell exhaustion– long-term
ex vivo expansion
3
Induced Pluripotent
Stem Cells (iPSCs)
introduction of reprogramming
factors.
• Have unlimited self-renewal
and can differentiate to any cell
type
• No ethical concern regarding
embryo destruction
http://learn.genetics.utah.edu/
4
Combining iPSC technology with adoptive T
cell therapy
Unlimited self-renewal
Off-the-shelf T cells
T cell development in vivo
Day : -3 0 2 3 5 8
Essential 8 RPMI + B27 + Ascorbic acid
CHIR9902 VEGF + FGF2
1
SB431542
Matrigel-coated plate
Netsrithong et al. Stem cell research & therapy, 2020
8
Morphology and expression of mesodermal markers
Day 5 Day 5
Day 0
CD34
CD31
Day 8 Day 8
CD34
Scale bar = 100 μm CD43
9
Induction of T Cells using OP9-DL4
Transfer HEPs
or HSPCs cells Collect suspension cells
Plate OP9-DL4 cells Transfer to a new
Transfer to
dish every 5 days
a new dish
Day : -2 OR -1 0 3 5 25
OP9 medium : α-MEM + 20 % FBS + 1% glutamine
OP9-DL4 cells
10
Generation of iT Cells using OP9-DL4
CD45+ CD5+ CD7+ gated Day 25
Morphology of differentiated cells CD45+ CD5+ CD7+ gated Single positive induction
on OP9-DL4 on Day 25
11
OP9-DL4 co-culture system
• Lack macrophage colony-
Bone marrow of stimulating factor
OP/OP MICE (MCSF/CSF1) which
would normally support
myelopoiesis
• Provide DL4, IL-7,
CXCL12 and SCF in
OP9 stromal cell line culture to support T cell
development
Overexpress
Delta-like 4 • Contamination of
xenogeneic antigen
OP9-DL4 co-culture
T-iPSCs HSPCs T cells
Feeder-free protocol
Day : -3 0 2 3 5 8
Essential 8 RPMI + B27 + Ascorbic acid
CHIR9902 VEGF + FGF2
1
SB431542 IL-3 + IL-6 + SCF +
FLT3L
Matrigel-coated plate
Expression of hematopoietic makers
-Cytokines +Cytokines on Day 5
Live cell gated
+SB on Day 5
CD34
+SB on Day 3
CD43
T Cell differentiation
15
16
Induction of T Cells using StemSpan™ T
Cell Generation Kit
Transfer Day 8
Collect suspension cells
HSPCs
Coat plate Transfer to a new
Transfer to
dish every 14 days
a new dish
Day : -1 0 3 7 14 28
StemSpan™ Serum-Free Expansion Medium II
Supplement 1 Supplement 2
17
T cell differentiation of Day 8 SB cells (added SB on Day 3)
-Cytokines
+Cytokines
18
19
HSPC differentiation
iPSCs ME HEP HSPCs
Day : -3 0 2 3 5 8
Essential 8 RPMI + B27 + Ascorbic acid
CHIR9902 VEGF + FGF2
1
SB431542 IL-3 + IL-6 + SCF +
FLT3L
Vitronectin-coated plate
T cell differentiation of Day 8 SB cells (added SB on Day 3)
-Cytokines
+Cytokines
20
21
HSPC differentiation
iPSCs ME HEP HSPCs
Day : -3 0 2 3 5 8
Essential 8 RPMI + B27 + Ascorbic acid
CHIR9902 VEGF + FGF2
1
SB431542 IL-3 + IL-6 + SCF +
FLT3L
Vitronectin-coated plate
Expression of hematopoietic makers
-Cytokines +Cytokines
Live cell gated
CD34
CD43
23
Day 8
HSPCs
4 weeks
4 weeks
4 weeks
SS medium + SS coating
27
Day 8
HSPCs
4 weeks
4 weeks
Medium 1 in DL4+VCAM1
4 weeks
Medium 2 in DL4+VCAM1
28
HSPC differentiation
iPSCs ME HEP HSPCs
Day : -3 0 2 3 5 8
Essential 8 RPMI + B27 + Ascorbic acid
CHIR9902 VEGF + FGF2
1
SB431542
Vitronectin-coated plate
Expression of hematopoietic makers
Day 5 Day 8
Live cell gated
CD34
CD43
Contramination!!!
31
HSPC differentiation
iPSCs ME HEP HSPCs
Day : -3 0 2 3 5 8
Essential 8 RPMI + B27 + Ascorbic acid
CHIR9902 VEGF + FGF2
1
SB431542
Vitronectin-coated plate
32
HSPC differentiation
iPSCs ME HEP HSPCs
Day : -3 0 2 3 5 8
Essential 8 IMDM
CHIR9902 VEGF + FGF2
1
SB431542
Vitronectin-coated plate
Morphology of hematopoietic makers
KDR
CD235a
Expression of hematopoietic makers
CD34
CD43
36
37
Day 8
HSPCs
4 weeks
4 weeks
Medium 1 in DL4+VCAM1